Avilar Therapeutics financing up to $75M to boost extracellular protein degraders pipeline
Avilar Therapeutics has raised additional funding with an expanded syndicate of new investors to support…
Avilar Therapeutics has raised additional funding with an expanded syndicate of new investors to support…
An impressive crowd gathered at Chiesi Pharmaceutical Group yesterday (November 21) to mark the much-anticipated…
Immunotherapy is a cutting-edge approach to treating cancer by turning the patient’s own immune system…
An essential step in preclinical drug development is confirming the specific binding of the novel…
The malignant brain tumor type medulloblastoma can become resistant to therapy, which can cause relapse. …
Encoded in the DNA, a protein may be represented as a thread of hundreds of…
Forcefield Therapeutics, has presented positive preclinical data on three proteins identified by it FunSel platform…
Membrane proteins are key targets for many drugs. Some of them, called transporters, move certain…
A-Alpha Bio, a synthetic biology and machine learning company that measures and engineers protein-protein interactions…
Amphista Therapeutics Ltd., has selected Domainex Ltd as one of its trusted partners to provide…
Next-generation proteomics has a vital role to play in the search for new biomarkers of…
An Israeli start-up is using technology to clean up labels in products mimicking meat using…